Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
OncoC4, Inc.
National Institutes of Health Clinical Center (CC)
Arcus Biosciences, Inc.
Atavistik Bio, Inc
AstraZeneca
Jonsson Comprehensive Cancer Center
ImmunityBio, Inc.
Memorial Sloan Kettering Cancer Center
Seagen Inc.
HiFiBiO Therapeutics
Sensei Biotherapeutics, Inc.
Cancer Research UK
OncoC4, Inc.
Klus Pharma Inc.
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
SOLTI Breast Cancer Research Group
Xencor, Inc.
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc